ARCA Biopharma Price on March 4, 2024
If you're considering investing in ARCA Stock, it is important to understand the factors that can impact its price. We have found zero technical indicators for ARCA Biopharma, which you can use to evaluate the volatility of the firm.
ARCA Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
ARCA |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
ABIO |
Based on monthly moving average ARCA Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ARCA Biopharma by adding ARCA Biopharma to a well-diversified portfolio.
ARCA Biopharma Valuation on March 4, 2024
It is possible to determine the worth of ARCA Biopharma on a given historical date. On March 4, 2024 ARCA was worth 11.07 at the beginning of the trading date compared to the closed value of 10.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ARCA Biopharma stock. Still, in general, we apply an absolute valuation method to find ARCA Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ARCA Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ARCA Biopharma's related companies.
Open | High | Low | Close | Volume | |
10.50 | 10.69 | 10.31 | 10.56 | 819.00 | |
03/04/2024 | 11.07 | 11.07 | 10.26 | 10.63 | 1,725 |
10.56 | 10.63 | 10.25 | 10.56 | 3,980 |
Backtest ARCA Biopharma | | | ARCA Biopharma History | | | ARCA Biopharma Valuation | Previous | Next |
ARCA Biopharma Trading Date Momentum on March 4, 2024
On March 05 2024 ARCA Biopharma was traded for 10.56 at the closing time. The top price for the day was 10.63 and the lowest listed price was 10.25 . The trading volume for the day was 4 K. The trading history from March 5, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.66% . The overall trading delta against the current closing price is 1.13% . |
ARCA Biopharma Fundamentals Correlations and Trends
By evaluating ARCA Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ARCA Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ARCA financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ARCA Biopharma Stock history
ARCA Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ARCA is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ARCA Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ARCA Biopharma stock prices may prove useful in developing a viable investing in ARCA Biopharma
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. The company was incorporated in 2004 and is headquartered in Westminster, Colorado. Arca Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.
ARCA Biopharma Stock Technical Analysis
ARCA Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
ARCA Biopharma Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
ARCA Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ARCA Biopharma December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how ARCA Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ARCA Biopharma shares will generate the highest return on investment. By undertsting and applying ARCA Biopharma stock market strength indicators, traders can identify ARCA Biopharma entry and exit signals to maximize returns
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in ARCA Stock
If you are still planning to invest in ARCA Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ARCA Biopharma's history and understand the potential risks before investing.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |